Satish Keshav
About
In The Last Decade
Satish Keshav
109 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Immunology 3.3k
- Epidemiology 1.7k
- Genetics 1.6k
- Molecular Biology 1.5k
- Surgery 979
Countries citing papers authored by Satish Keshav
This map shows the geographic impact of Satish Keshav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satish Keshav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satish Keshav more than expected).
Fields of papers citing papers by Satish Keshav
This network shows the impact of papers produced by Satish Keshav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satish Keshav. The network helps show where Satish Keshav may publish in the future.
Co-authorship network of co-authors of Satish Keshav
This figure shows the co-authorship network connecting the top 25 collaborators of Satish Keshav. A scholar is included among the top collaborators of Satish Keshav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satish Keshav. Satish Keshav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Analysis of liver infiltrating lymphocytes in primary sclerosing cholangitis by surface antigen and single cell RNA sequencing using fine needle aspiration of the liver | 1 |
| 2 | 9 | |
| 3 | 14 | |
| 4 | 29 | |
| 5 | 123 | |
| 6 | 69 | |
| 7 | 130 | |
| 8 | 0 | |
| 9 | Which activity index for ulcerative colitis? evaluation of the size and effect of inter_observer variation in clinical, endoscopic and composite indices | 1 |
| 10 | HOW MUCH AGREEMENT IS THERE BETWEEN HISTOLOGICAL, ENDOSCOPIC AND CLINICAL ASSESSMENTS OF REMISSION IN ULCERATIVE COLITIS? | 9 |
| 11 | MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B | 1 |
| 12 | Single nucleotide polymorphisms (SNPs) of the NOD2/CARD15 gene are associated with significant increases in disease relapse and death in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemia | 1 |
| 13 | 1 | |
| 14 | Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory & clinical activity in the treatment of Crohn's disease | 13 |
| 15 | 20 | |
| 16 | Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis | 6 |
| 17 | 399 | |
| 18 | Recombinant factor VIIA is used in a Jehova's Witness with liver cirrhosis to correct prothrombin time, bleeding time, and thromboelastographic parameters, enabling safe percutaneous injection of hepatocellular carcinoma | 1 |
| 19 | CYTOKINE PROFILES IN HIV-INFECTED INTESTINAL-MUCOSA | 1 |
| 20 | 90 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.